Led Kyron.bio's €5.5M seed for precision glycan engineering in antibody therapeutics.
Kyron
Kyron.bio unlocks superior protein therapeutics by harnessing the power of glycan modifications, focusing on glycan engineering to create better therapies and transform patient outcomes.